Previous 10 | Next 10 |
Energy Focus (NASDAQ: EFOI ) -52% on Q4 earnings . More news on: Energy Focus, Inc., Evoke Pharma, Inc., Apyx Medical Corporation, Stocks on the move, Read more ...
Evoke Pharma (NASDAQ: EVOK ) has received a Complete Response Letter (CRL) from the FDA for its 505(b)(2) NDA for Gimoti for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. More news on: Evoke Pharma, Inc., Healthcare stocks news, Stocks on the mov...
SOLANA BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administ...
Advaxis (NASDAQ: ADXS ) +40% on positive ADXS-NEO data . More news on: Advaxis, Inc., Pulmatrix, Inc., Evoke Pharma, Inc., Stocks on the move, Read more ...
Gainers: Atossa Genetics (NASDAQ: ATOS ) +242% . Hancock Jaffe Laboratories (NASDAQ: HJLI ) +41% . WageWorks (NYSE: WAGE ) +30%. Smith Micro Software (NASDAQ: SMSI ) +31% . Akari Therapeutics (NASDAQ: AKTX ) +30% . KalVista Pharmaceuticals (NASDAQ: KALV ) +29% . MongoDB (NASDA...
Atossa Genetics (NASDAQ: ATOS ) +223% on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...
Thinly traded nano cap Evoke Pharma (NASDAQ: EVOK ) is up 19% premarket on modestly higher volume following its announcement that it has submitted its response to the FDA's multidisciplinary review (DR) letter related to its Gimoti marketing application. More news on: Evoke P...
SOLANA BEACH, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has submitted its response to the U.S. Food and Drug Administration’s (FDA)...
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Evoke Pharma Tumbles After Preliminary NDA Review News: Recently, Evoke Pharma ( EVOK ) tumbled by 51% on the announcement that the FDA was not sat...
Evoke Pharma (NASDAQ: EVOK ): Q4 GAAP EPS of -$0.10 misses by $0.02. More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...